• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC, INC. PROTECTA XT CRT-D; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CARDIAC RESYNCHRONIZATIO

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC, INC. PROTECTA XT CRT-D; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CARDIAC RESYNCHRONIZATIO Back to Search Results
Model Number D314TRG
Device Problems Intermittent Capture (1080); Failure to Capture (1081); Pacing Problem (1439); High Capture Threshold (3266)
Patient Problems Cardiac Arrest (1762); Non specific EKG/ECG Changes (1817); Dizziness (2194)
Event Type  Injury  
Manufacturer Narrative
Medtronic was made aware of this event through a search of literature publications.It was not possible to ascertain specific device information from the literature publication or to match the event with previously reported events.This information is based entirely on journal literature.All information provided is included in this report.Patient information is limited due to confidentiality concerns.Without a lot number or device serial number, the manufacturing date cannot be determined.A request for additional information will be made and upon receipt a supplemental report will be submitted accordingly.Referenced article: ventricular asystole in a crt-d device.What is the mechanism? pacing clin electrophysiol.2019; 42:1243-1245.Doi: 10.1111/pace.13773.If information is provided in the future, a supplemental report will be issued.
 
Event Description
A journal article was reviewed that contained information regarding a case study around the mechanism of ventricular asystole in a cardiac resynchronization therapy defibrillator (crt-d).It was reported that the patient presented with several episodes of presyncope over the course of a month.The patient was admitted and upon admission, a 13 second pause was observed.Overall, the patient had stable vital signs, however, interrogation of their crtd showed right ventricular (rv) lead elevated threshold.Left ventricular (lv) lead pacing was inhibited to allow for a rv capture test, which was normal function, but the capture management threshold testing was unsuccessful which resulted in asystole.A telemetry strip also showed intermittent capture.Ultimately, the rv lead was explanted and replaced.No further patient complications have been reported as a result of this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROTECTA XT CRT-D
Type of Device
DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CARDIAC RESYNCHRONIZATIO
Manufacturer (Section D)
MEDTRONIC, INC.
8200 coral sea street ne
mounds view MN 55112
Manufacturer (Section G)
MEDTRONIC, INC.
8200 coral sea street ne
mounds view MN 55112
Manufacturer Contact
paula bixby
8200 coral sea st ne
mounds view, MN 55112
7635055378
MDR Report Key10107087
MDR Text Key193421461
Report Number2182208-2020-00996
Device Sequence Number1
Product Code NIK
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P010031
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,literatur
Reporter Occupation Physician
Type of Report Initial
Report Date 06/01/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/01/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Model NumberD314TRG
Device Catalogue NumberD314TRG
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/05/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Life Threatening; Required Intervention;
Patient Age89 YR
-
-